The Multidisciplinary Association for Psychedelic Studies (MAPS) is a membership–based, IRS–approved 501 (c) (3) nonprofit research and educational organization. Our mission is 1) to treat conditions for which conventional medicines provide limited relief—such as posttraumatic stress disorder (PTSD), pain, drug dependence, anxiety and depression associated with end-of-life issues—by developing psychedelics and marijuana into prescription medicines; 2) to cure many thousands of people by building a network of clinics where treatments can be provided; and 3) to educate the public honestly about the risks and benefits of psychedelics and marijuana.
MAPS relies on the generous support of dues–paying members in order to fund our numerous research projects and educational projects. By becoming a MAPS member today, you will bring us closer to achieving our shared mission. Please join us at maps.org/donate
Anders Hattne commented on LSD-Assisted Psychotherapy for the Treatment of Anxiety Associated with Life Threatening Illnesses - Peter Gasser, M.D.
Awwwww.. we want to hear the case report!